Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03620188 · ClinicalTrials.gov registry record
Treatment Goals in Psoriatic Arthritis
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 250
- Enrollment target
NCT03620188: Completed study, sponsored by Johns Hopkins University.
NCT03620188 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03620188 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The PaGoPsA study objective is to ascertain if guideline-based psoriatic arthritis clinical care achieves individual patient goals as articulated by patients, and to identify predictors of achieving individual patient goals from psoriatic arthritis treatment.
Primary Outcome
The primary outcome determination is based on the patients' report of whether they are/are not at goal with their PsA treatment.
Interventions
- OTHER Standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2022-06-30 |
What the finished NCT03620188 record still lists
NCT03620188 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Standard of care is the first listed.
NCT03620188 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03620188 about?
NCT03620188 is a clinical study titled "Treatment Goals in Psoriatic Arthritis". The PaGoPsA study objective is to ascertain if guideline-based psoriatic arthritis clinical care achieves individual patient goals as articulated by patients, and to identify predictors of achieving individual patient goals from psoriatic arthritis treatment.
What is the current status of trial NCT03620188?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2018-12-20. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03620188?
The interventions under investigation include: Standard of care (OTHER).
Who is sponsoring clinical trial NCT03620188?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI